biote Corp.

biote Corp. (Nasdaq: BTMD) is a Southlake, Texas-based healthcare company focused on bioidentical hormone pellet therapy and personalized hormone optimization. The company entered the public markets through a de-SPAC merger with Haymaker Acquisition Corp. III, a blank-check vehicle sponsored by Haymaker Capital Management that completed its SPAC IPO in 2021. The Form 10-Q filed on August 17, 2021, under accession number 0001193125-21-249118, captures quarterly financial reporting from the company during the active de-SPAC transition period ahead of the business combination's close. biote operates in the healthcare sector, partnering with licensed practitioners to provide individualized hormone therapy protocols. For full filing history, deal timelines, and SPAC analytics on BTMD and thousands of other transactions, sign up for a free SpacDesk account today.